A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/06/2002	CN1378538A Diazocine-diketone derivatives and use as tryptase inhibitor thereof
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery
11/06/2002	CN1378534A Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of coagulation cascade
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002	CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/06/2002	CN1378471A Dual adhesive transdermal drug delivery system
11/06/2002	CN1378460A Skin immune function controlling agents
11/06/2002	CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002	CN1378454A Aminoalkylenephosphonates for treatment of bone disorders
11/06/2002	CN1378453A Neuropathy remedies
11/06/2002	CN1378452A Orally disintegrating composition containing mirtazapine
11/06/2002	CN1378451A Pharmaceuticla ocmpositions for treating psoriasis
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/06/2002	CN1378449A Iron chelators and use thereof
11/06/2002	CN1378448A Torsemide polymorphs
11/06/2002	CN1378447A Use of cell membrane penetrating indigoid bisindole derivatives
11/06/2002	CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002	CN1378445A Drug releasing biodegradable fiber implant
11/06/2002	CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels
11/06/2002	CN1378441A Use of conjugated linoleic acid (CLA) for topical treatment of cellulite
11/06/2002	CN1378423A Active ingredient compositions having insecticidal and acaricidal properties
11/06/2002	CN1377897A Viva pertusa polyose for regulating blood fat and its preparing method
11/06/2002	CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1377698A Nano woman's cleaning and nursing aloe lotion and its preparing method
11/06/2002	CN1377691A Medicine for curing tumor and preparing method
11/06/2002	CN1377689A Traditional Chinese medicine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method
11/06/2002	CN1377682A Bone-setting pain stopping paste
11/06/2002	CN1377680A Process for preparing broad spectrum anti-virus medicine and its use
11/06/2002	CN1377675A Pepper-pueraria root compound Chinese medicine preparation and its preparing process
11/06/2002	CN1377650A Medicine for curing cholecystopathy
11/06/2002	CN1377649A Use of hydroxy asiaticoside for preparingm edicine for curing depression
11/06/2002	CN1377648A Imiquimod or its derivative liposome for local skin and its preparing method and use
11/06/2002	CN1377647A 4-mercaptopyrrolidinyl derivative as fernesyl transferase inhibitor
11/06/2002	CN1377646A Anti-cancer medicine and its preparing method
11/06/2002	CN1377645A Tea polyphenol buccal tablet for preventing and curing tooth decay and its preparing method
11/06/2002	CN1377644A Anti-leukemia medicine
11/06/2002	CN1377643A Health article containing tea polyphenol for resisting poor uranium bomb and preventing leukemia
11/06/2002	CN1377642A Use of compound for preparing medicine for curing and preventing non-insulin dependent diabetes or obesity
11/06/2002	CN1377641A Medicine for curing pneumoconiosis
11/06/2002	CN1377640A External preparatino for skin
11/06/2002	CN1093861C 1-methylcarbapenem derivatives
11/06/2002	CN1093860C Pyridazino-[4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
11/06/2002	CN1093859C Novel indole-2,3-dione-3-oxime derivatives
11/06/2002	CN1093858C Quinoline and quinozoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
11/06/2002	CN1093857C New piperazine and piperidine compounds
11/06/2002	CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/06/2002	CN1093855C New compsn. containing acid-labile benzimidazole and process for its prepn.
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/06/2002	CN1093767C Protein kinase C inhibitors
11/06/2002	CN1093766C Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization
11/06/2002	CN1093763C Anti-cancer substance suppressing cancerous metastasis
11/06/2002	CN1093762C Aqueous suspension of 9-hydroxyrisperidone fatty and esters
11/06/2002	CN1093761C New pharmacological use of all-receptor antagonists
11/06/2002	CN1093760C Use of carbazole compounds for treating congenstive heart failure medicine
11/06/2002	CN1093759C 蛋白激酶c抑制剂 Protein kinase c inhibitor
11/06/2002	CN1093755C Topical composition for inhibiting hair growth
11/06/2002	CA2408401A1 Compositions containing folic acid and reduced folate
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/05/2002	US6476263 Compounds for inhibiting β-amyloid peptide release and/or its synthesis
11/05/2002	US6476236 Synthesis of 2-cyanoaziridine-1-carboxamide
11/05/2002	US6476235 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
11/05/2002	US6476214 Inhibition of cytokine production
11/05/2002	US6476207 Genes and gene expression products that are differentially regulated in prostate cancer
11/05/2002	US6476205 2′ Modified oligonucleotides
11/05/2002	US6476203 Safe pharmaceutical composition for treating and preventing infertility and increasing immune function
11/05/2002	US6476201 Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476079 Devices for the delivery of drugs having antiprogestinic properties
11/05/2002	US6476078 Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476074 Method and composition for treatment of erectile dysfunction
11/05/2002	US6476073 Method of treating a hangover by enhancing the effectiveness of the human immune system
11/05/2002	US6476072 Method of treating menstrual pain by enhancing the effectiveness of the human immune system
11/05/2002	US6476071 Correcting polymorphic metabolic dysfunction with (−)-hydroxycitric acid
11/05/2002	US6476068 Platinum derivative pharmaceutical formulations
11/05/2002	US6476067 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2002	US6476066 Anti-first-pass effect compounds
11/05/2002	US6476065 Antitumor agents
11/05/2002	US6476064 Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
11/05/2002	US6476063 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/05/2002	US6476062 Chemokine receptor antagonists
11/05/2002	US6476060 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
11/05/2002	US6476059 Use of polycyclic 2-aminothiazole systems for the treatment of obesity
11/05/2002	US6476053 Mycobacterial inhibitors
11/05/2002	US6476052 Isoindolines, method of use, and pharmaceutical compositions
11/05/2002	US6476051 For therapy of psychosis, acute mania, mild anxiety states, or depression in combination with psychotic episodes
11/05/2002	US6476049 1-formyl-n-(2-(4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1 -piperidinyl)) ethyl isonipecotic acid amide or analogs thereof
11/05/2002	US6476047 Good bioavailability and powerful analgesic activity based on calcium channel blockade.
11/05/2002	US6476044 Use of morphine derivatives as medicaments for the treatment of neuropathic problems
11/05/2002	US6476043 Use of camptothecin derivatives, with reduced gastrointestinal toxicity
11/05/2002	US6476042 Combination therapy for the treatment of migraine
11/05/2002	US6476041 1,4 substituted piperidinyl NMDA/NR2B antagonists
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476039 Acylurea containing quinazoline derivatives

1 ... 5660 5661 5662 5663 5664 5665 5666 5667 5668 5669 5670 5671 5672 5673 5674 5675 5676 5677 5678 5679 5680 ... 7860